Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FEMY
#4602
Femasys Inc. Common Stock
0.4
3
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-24.56%
6 month change
-23.21%
Year Change
-61.61%
Previous Close
0.4
3
Open
0.4
3
Bid
Ask
Low
0.4
3
High
0.4
3
Volume
6
Markets
US Stock Market
Healthcare
FEMY
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
27.15 M
27.24 M
32.58 M
58.48 M
60.39 M
—
Valuation ratios
Enterprise value
31.82 M
37.39 M
35.59 M
17.46 M
28.71 M
119.15 M
Price to earnings ratio
-1.29
-1.37
-1.12
-0.49
-1.23
-4.21
Price to sales ratio
15.04
16.75
12.25
4.92
9.94
43.86
Price to cash flow ratio
-1.26
-1.46
-1.19
-0.5
-1.22
-4.37
Price to book ratio
10.63
1.31
1.92
1.02
3.88
8.12
Enterprise value to EBITDA ratio
-2.08
-2.06
-2.05
-1.11
-1.14
-6.35
Profitability ratios
Return on assets %
-0.41
-0.44
-0.33
-0.26
-0.19
-1.23
Return on equity %
-2.22
-2.95
-3.04
-0.92
-0.67
-7.59
Return on invested capital %
-234.26
-208.67
-145.61
-132.51
-187.56
-674.35
Gross margin %
66.92
65.64
61.35
59.71
62.73
249.44
Operating margin %
-812.03
-1 600.11
-941.09
-500.93
-568.33
-3 610.46
EBITDA margin %
-737.75
-1 470.73
-822.98
-428.54
-527.94
-3 250.18
Net margin %
-881
-1 727.94
-1 120.52
-575.11
-485.66
-3 909.23
Liquidity ratios
Quick ratio
0.58
0.54
0.41
0.61
2.95
4.51
Current ratio
0.93
0.93
0.89
1.16
4.53
7.5
Inventory turnover
0.08
0.03
0.03
0.05
0.05
0.17
Asset turnover
0.04
0.03
0.03
0.05
0.04
0.15
Solvency ratios
Debt to assets ratio
0.43
0.54
0.53
0.09
0.15
1.31
Debt to equity ratio
2.35
3.58
4.88
0.31
0.54
9.31
Long term debt to total assets ratio
0.43
0.43
0.44
0.02
-0.43
0.46
Long term debt to total equity ratio
2.35
2.89
4.03
0.06
-1.53
5.46
Per share metrics
Operating cash flow per share
-0.23
-0.19
-0.15
-0.13
-0.11
-0.58
EBIT per share
-0.21
-0.22
-0.13
-0.09
-0.12
-0.56
EBITDA per share
-0.19
-0.2
-0.12
-0.08
-0.11
-0.5
Total debt per share
0.24
0.28
0.25
0.03
0.08
0.65
Cash per share
0.16
0.15
0.11
0.11
0.23
0.61
Net current asset value per share
0.36
0.36
0.34
0.3
0.42
1.42
Tangible book value per share
0.1
0.08
0.05
0.11
0.14
0.38
Working capital per share
-0.03
-0.03
-0.04
0.04
0.32
0.3
Book value per share
0.1
0.08
0.05
0.11
0.15
0.39
News
Femasys begins enrollment in pivotal trial for FemBloc device
Lake Street initiates Femasys stock coverage with buy rating
Femasys receives CPT code approval for infertility treatment
Femasys expands European presence with Swiss distribution deal
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
PharmaCyte Biotech stock soars after successful Femasys stake sale
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential